Medical News

RSS

Why we 'lust for blood'

We are fascinated with the lurid details of sensational murder trials. Horror fiction and slasher movies thrill us-the gorier the better. When we drive by the scene of an accident, we're compelled to slow down. And it's no secret that brutal video games are solid moneymakers. Why do we thirst for the frighteningly grotesque? In The "LUST FOR BLOOD: WHY WE ARE FASCINATED BY DEATH, MURDER, HORROR, AND VIOLENCE" veteran psychologist Jeffrey A. Kottler explains our dark desire for guts, gore, and the gruesome.

20 Apr 2011

Report: Impact of Ryan's 'Roadmap' on health law unclear

A report by the Congressional Research Service found that neither the House-passed budget resolution nor the "Roadmap to Prosperity" document provide enough detail to make a determination.

20 Apr 2011

Sagent prices initial public offering at $16.00 per share

Sagent Pharmaceuticals announced the upsizing and pricing of its initial public offering. The size of the offering has been increased from the previously announced 5,000,000 shares of common stock to 5,750,000 shares of common stock at a price to the public of $16.00 per share. The shares are scheduled to begin trading on The NASDAQ Global Market on April 20, 2011 under the ticker symbol "SGNT."

20 Apr 2011

Springer to publish new journal of Society of Behavioral Medicine

Starting in 2011, Springer will publish Translational Behavioral Medicine: Practice, Policy, Research (TBM), a journal of the Society of Behavioral Medicine. The journal will debut with a special section, "Information Technology and Evidence Implementation."

20 Apr 2011

Chronic inflammation due to infection may lead to cancer

A new study shows how inflammation can help cause cancer. Chronic inflammation due to infection or to conditions such as chronic inflammatory bowel disease is associated with up to 25 percent of all cancers.

20 Apr 2011

Diabetes in Control announces clinical slide presentation library for medical community

Diabetes in Control (http://www.diabetesincontrol.com), an e-newsletter dedicated to keeping clinicians current with the rapid changes in diabetes care, expands its quest to provide them with the best tools for their practice.

20 Apr 2011

Cognitive behavior therapy eases depressive symptoms, improves cardiovascular health in diabetics

Frequently, depression and diabetes go hand in hand. And depression can be a major obstacle for people living with diabetes, making it less likely they'll stick to a medicine schedule or exercise regimen.

20 Apr 2011

SERI selects AB SCIEX TripleTOF 5600 system to test chronic eye inflammations

AB SCIEX, a global leader in life science analytical technologies, today announced that the Singapore Eye Research Institute, an internationally known eye research center, will advance biomarker candidates it identified for chronic inflammatory eye conditions into large-scale clinical trials for validation with the AB SCIEX TripleTOF™ 5600 System.

20 Apr 2011

Antibodies to non-human sugar molecule may be useful for early detection of cancer

Researchers at the University of California, San Diego School of Medicine say antibodies to a non-human sugar molecule commonly found in people may be useful as a future biomarker for predicting cancer risk, for diagnosing cancer cases early and, in sufficient concentration, used as a treatment for suppressing tumor growth.

20 Apr 2011

Acorda receives patent for AMPYRA tablets to improve walking in MS patients

Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office has allowed U.S. Patent Application No. 11/010,828 entitled "Sustained Release Aminopyridine Composition."

20 Apr 2011

Alcohol intake increases risk of many cancers

A large group of distinguished scientists published a very detailed and rather complex paper describing the association between alcohol consumption and cancer in the BMJ. It is based on data from the EPIC study in Europe, with a mean follow up of 8.8 years for more than 300,000 subjects.

20 Apr 2011

Tissue Genesis commences PVD clinical trials with adipose-derived adult stem cell-coated vascular grafts

Tissue Genesis, Inc., an emerging leader in adult stem cell and regenerative medicine, announced today that it has begun clinical trials for peripheral vascular disease (PVD) with adipose (fat) derived adult stem cell-coated vascular grafts at the University of Louisville Hospital. Tissue Genesis is the first to initiate a FDA-approved trial using the patient's own adipose-derived adult stem cells (ASCs) prepared at the point-of-care.

20 Apr 2011

Dental diagnosis and treatment for snoring and sleep apnoea

Over seven million people in Spain are at risk of developing sleep apnoea (SA), a health problem caused by obstructed air intake during sleep.

20 Apr 2011

Ampio raises $12.732 million through private placement of common stock

Ampio Pharmaceuticals, Inc. announced today the successful completion of a private placement from which Ampio received gross proceeds of $12.732 million.

20 Apr 2011

Positive results from first human masitinib phase 2 study in Alzheimer's disease published in peer-reviewed journal

AB Science SA, a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), announces the publication of results from the first human phase 2 study of masitinib carried-out in the treatment of Alzheimer's disease.

20 Apr 2011

Sustained participation of older people can prevent falls in care home and hospital settings

New research has indicated that more should be done to involve older people with interventions to prevent falls in care home and hospital settings.

20 Apr 2011

MSF calls on African governments, WHO to switch to newer, more expensive treatment for severe malaria

Nearly 200,000 deaths from severe malaria could be averted if African governments replaced the low-cost antimalarial quinine with the more expensive but more effective drug artesunate, according to a report (.pdf) released Tuesday by Medicins Sans Frontieres (MSF), Reuters reports (Kelland, 4/19).

20 Apr 2011

FHI to stop FEM-PrEP study of HIV prevention among heterosexual women

On the heels of Centers for Disease Control announcement earlier today that an ongoing study of the use of Gilead's top selling AIDS treatment, Truvada, as a possible form of pre-exposure prophylaxis for HIV prevention in women is being abruptly halted because the, "…trial could not demonstrate efficacy," the AIDS Healthcare Foundation renewed its call on Gilead Sciences to slow its fast track pursuit of its application for FDA approval of use of its AIDS drug as a possible form of HIV prevention.

20 Apr 2011

OSU biophysicist leverages computer cluster to develop drug to block small protein molecule IL-6

An Ohio State biophysicist used a supercomputer to search thousands of molecular combinations for the best configuration to block a protein that can cause breast or prostate cancer.

20 Apr 2011

Biomerix receives Health Canada licenses for REVIVE and ASSURE Hernia Repair Meshes

Biomerix Corporation announced today it has received two Class III Medical Device Licenses by Health Canada for its REVIVE and ASSURE Hernia Repair Meshes.

20 Apr 2011

Medical News

Why we 'lust for blood'

Report: Impact of Ryan's 'Roadmap' on health law unclear

Sagent prices initial public offering at $16.00 per share

Springer to publish new journal of Society of Behavioral Medicine

Chronic inflammation due to infection may lead to cancer

Diabetes in Control announces clinical slide presentation library for medical community

Cognitive behavior therapy eases depressive symptoms, improves cardiovascular health in diabetics

SERI selects AB SCIEX TripleTOF 5600 system to test chronic eye inflammations

Antibodies to non-human sugar molecule may be useful for early detection of cancer

Acorda receives patent for AMPYRA tablets to improve walking in MS patients

Alcohol intake increases risk of many cancers

Tissue Genesis commences PVD clinical trials with adipose-derived adult stem cell-coated vascular grafts

Dental diagnosis and treatment for snoring and sleep apnoea

Ampio raises $12.732 million through private placement of common stock

Positive results from first human masitinib phase 2 study in Alzheimer's disease published in peer-reviewed journal

Sustained participation of older people can prevent falls in care home and hospital settings

MSF calls on African governments, WHO to switch to newer, more expensive treatment for severe malaria

FHI to stop FEM-PrEP study of HIV prevention among heterosexual women

OSU biophysicist leverages computer cluster to develop drug to block small protein molecule IL-6

Biomerix receives Health Canada licenses for REVIVE and ASSURE Hernia Repair Meshes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News